Thank you for joining us for GRACE's first Blood Cancer ONCTalk
En este video, la Dra. Velázquez Mañana analiza las mutaciones del EGFR, los diferentes subtipos de cáncer de pulmón y cómo determinar cuál es el mejor tratamiento en general.
To watch the complete playlist, click here.
Special thanks to Genentech, BMS, Takeda, Johnson & Johnson, and Daiichi-Sankyo for their sponsorship of this program.
Head and neck cancers linked to human papillomavirus (HPV) are very different from those caused by tobacco or alcohol. The good news is that HPV-positive cancers usually respond better to treatment and often have better outcomes.
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
In these videos, the panel discusses treatment options for a patient diagnosed with EGFR Exon 19 Deletion NSCLC and looks at data from the Laura Trial. They also discuss treatment options for a patient with a smoking history and diagnosis of small cell lung cancer, and how the Adriatic Study factors into decisions.
4487.jpg?itok=LooO274g)
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.